Loading...
Guardian Pharmacy Services, Inc.
GRDN•NYSE
HealthcareMedical - Distribution
$20.65
$-0.27(-1.29%)
Guardian Pharmacy Services, Inc. (GRDN) Financial Performance & Statements
Review Guardian Pharmacy Services, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
17.42%
↑ 17.42%
Operating Income Growth
-253.67%
↓ 253.67%
Net Income Growth
-465.19%
↓ 465.19%
Operating Cash Flow Growth
-18.16%
↓ 18.16%
Operating Margin
-4.51%
↓ 4.51%
Gross Margin
19.78%
↑ 19.78%
Net Profit Margin
-6.29%
↓ 6.29%
ROE
-74.40%
↓ 74.40%
ROIC
-30.66%
↓ 30.66%
Guardian Pharmacy Services, Inc. (GRDN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Guardian Pharmacy Services, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|
| Revenue | $338.57M | $314.39M | $300.04M |
| Cost of Revenue | $271.46M | $253.51M | $238.75M |
| Gross Profit | $67.10M | $60.88M | $61.29M |
| Gross Profit Ratio | $0.20 | $0.19 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $50.35M | $165.49M | $44.28M |
| Operating Expenses | $50.35M | $165.49M | $44.28M |
| Total Costs & Expenses | $321.81M | $419.006M | $283.03M |
| Interest Income | $0.00 | $0.00 | $0.00 |
| Interest Expense | $421000.00 | $1.03M | $1.07M |
| Depreciation & Amortization | $5.15M | $4.99M | $0.00 |
| EBITDA | $21.80M | -$99.62M | $16.91M |
| EBITDA Ratio | $0.06 | -$0.32 | $0.06 |
| Operating Income | $16.75M | -$104.61M | $17.005M |
| Operating Income Ratio | $0.05 | -$0.33 | $0.06 |
| Other Income/Expenses (Net) | -$534000.00 | -$1.03M | -$1.16M |
| Income Before Tax | $16.22M | -$105.64M | $15.85M |
| Income Before Tax Ratio | $0.05 | -$0.34 | $0.05 |
| Income Tax Expense | $4.38M | $176000.00 | $0.00 |
| Net Income | $11.94M | -$112.64M | $10.62M |
| Net Income Ratio | $0.04 | -$0.36 | $0.04 |
| EPS | $0.20 | -$1.84 | $0.17 |
| Diluted EPS | $0.20 | -$1.84 | $0.17 |
| Weighted Avg Shares Outstanding | $61.14M | $61.14M | $60.84M |
| Weighted Avg Shares Outstanding (Diluted) | $61.14M | $61.14M | $60.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan